lncRNA LINC-PINT controls lymphatic function and inflammatory profile in lymphedema
Science Advances · 2025
DOI: 10.1126/sciadv.aea2960 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Nathalie Laugero und 11 weiteren Autor:innen. Beteiligte Einrichtung: I2MC, Université de Toulouse, Inserm UMR 1297, Toulouse, France. Hauptthemen laut MEDLINE: RNA, Long Noncoding, Lymphedema, Inflammation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Horizon 2020 Framework Programme, Fondation pour la Recherche Médicale.
Abstract (Originalsprache)
Lymphedema is a lymphatic dysfunction leading to an accumulation of fluid and fat in the arm or leg. Here, we performed noncoding RNA profiling of human breast cancer–induced secondary lymphedema. We identified the long intergenic non–protein coding RNA, P53-induced transcript ( LINC-PINT ), as essential for the lymphedema development. LINC-PINT is the most expressed lncRNA in human lymphatic endothelial cells (LECs) under stress condition. Knocking down LINC-PINT in LECs promotes the expression of inflammation-related genes. Mechanistically, ATAC-seq revealed that LINC-PINT induces the transcription of genes involved in lymphangiogenesis and immune cell adhesion by increasing chromatin accessibility. Notably, LINC-PINT deficiency impairs LEC proliferation, migration, and sprouting. Conditional deletion of Lnc-Pint in mouse lymphatic endothelium (Lnc-Pint lecko ) leads to a reduction in dermal lymphatic network density. Lnc-Pint lecko mice exhibit decreased lymphedema, reduced dermal backflow, fibrosis, and inflammation. Our findings unveil a crucial molecular role of LINC-PINT in lymphatic function and hold substantial clinical implications for lncRNA as biomarker of lymphedema.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- I2MC, Université de Toulouse, Inserm UMR 1297, Toulouse, France.
- Service de Médecine Vasculaire, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
ORCID-Profile: Nathalie Laugero, Claire Peghaire, Elisa Balzan, Tangra Draia-Nicolau, Julie Malloizel-Delaunay, Florent Morfoisse, Anne-Catherine Prats, Eric Lacazette, Barbara Garmy-Susini
Förderung
- Horizon 2020 Framework Programme
- Fondation pour la Recherche Médicale
Zitieren
APA
Laugero, N., Peghaire, C., Verdu, L., Balzan, E., Draia-Nicolau, T., Sylvestre, R., Malloizel-Delaunay, J., Bura-Rivière, A., Morfoisse, F., Prats, A. C., Lacazette, E., & Garmy-Susini, B. (2025). lncRNA LINC-PINT controls lymphatic function and inflammatory profile in lymphedema. Science Advances. https://doi.org/10.1126/sciadv.aea2960
Vancouver
Laugero N, Peghaire C, Verdu L, Balzan E, Draia-Nicolau T, Sylvestre R, et al. lncRNA LINC-PINT controls lymphatic function and inflammatory profile in lymphedema. Science Advances. 2025. doi:10.1126/sciadv.aea2960
BibTeX
@article{Laugero2025,
author = {Laugero, Nathalie and Peghaire, Claire and Verdu, Léna and Balzan, Elisa and Draia-Nicolau, Tangra and Sylvestre, Roxane and Malloizel-Delaunay, Julie and Bura-Rivière, Alessandra and Morfoisse, Florent and Prats, Anne-Catherine and Lacazette, Eric and Garmy-Susini, Barbara},
title = {lncRNA LINC-PINT controls lymphatic function and inflammatory profile in lymphedema},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.aea2960}
}
EUVIMED